[In vitro antibacterial activity of drugs from the group of ethanolamine, phenothiazine and aminoalkyl derivatives with antihistaminic action].
D001419:Bacteria / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology; D002974:Clemastine / Q000494:pharmacology; D004111:Dimenhydrinate / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004983:Ethanolamines / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D010640:Phenothiazines / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D011398:Promethazine / Q000494:pharmacology
D004983:Ethanolamines; D006634:Histamine H1 Antagonists; D010640:Phenothiazines; D010880:Piperidines; C005795:thenalidine; D004155:Diphenhydramine; D002974:Clemastine; D011398:Promethazine; D004111:Dimenhydrinate; D002746:Chlorpromazine
Aktywność leków o działaniu przeciwhistaminowym z grupy pochodnych etanoloaminy, fenotiazyny i aminoalkili wobec wybranych gatunków bakterii in vitro.